Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100PNBN
Period2017-01-01 → 2017-12-31
Filed2022-11-17
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amends S100CP6F.

Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥229m2017-01-01 → 2017-12-31StandaloneNet sales
Revenue¥178m2016-01-01 → 2016-12-31StandaloneNet sales
Revenue¥121m2015-01-01 → 2015-12-31dStandaloneNet sales (5-year summary)
Revenue¥29m2014-01-01 → 2014-12-31dStandaloneNet sales (5-year summary)
Revenue¥1m2013-01-01 → 2013-12-31dStandaloneNet sales (5-year summary)
Operating income−¥1.1bn2017-01-01 → 2017-12-31StandaloneOperating income
Operating income−¥861m2016-01-01 → 2016-12-31StandaloneOperating income
Ordinary income−¥1.1bn2017-01-01 → 2017-12-31StandaloneOrdinary income
Ordinary income−¥864m2016-01-01 → 2016-12-31StandaloneOrdinary income
Ordinary income−¥855m2015-01-01 → 2015-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥726m2014-01-01 → 2014-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥625m2013-01-01 → 2013-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2017-01-01 → 2017-12-31StandaloneIncome before income taxes
Profit before tax−¥928m2016-01-01 → 2016-12-31StandaloneIncome before income taxes
Net income−¥1.1bn2017-01-01 → 2017-12-31StandaloneProfit loss
Net income−¥931m2016-01-01 → 2016-12-31StandaloneProfit loss
Net income−¥857m2015-01-01 → 2015-12-31dStandaloneNet income loss (5-year summary)
Net income−¥739m2014-01-01 → 2014-12-31dStandaloneNet income loss (5-year summary)
Net income−¥636m2013-01-01 → 2013-12-31dStandaloneNet income loss (5-year summary)
Total assets¥3.5bnat 2017-12-31StandaloneAssets
Total assets¥3.1bnat 2016-12-31StandaloneAssets
Total assets¥4.0bnat 2015-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.0bnat 2014-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.7bnat 2013-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥594mat 2017-12-31StandaloneLiabilities
Total liabilities¥523mat 2016-12-31StandaloneLiabilities
Net assets / equity¥2.9bnat 2017-12-31StandaloneNet assets
Net assets / equity¥2.6bnat 2016-12-31StandaloneNet assets
Net assets / equity¥3.5bnat 2015-12-31dStandaloneNet assets
Net assets / equity¥4.4bnat 2014-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥5.1bnat 2013-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.9bnat 2017-12-31StandaloneCash and deposits
Cash and deposits¥2.6bnat 2016-12-31StandaloneCash and deposits
Cash & equivalents¥1.9bnat 2017-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2016-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2015-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2014-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥5.4bnat 2013-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.1bn2017-01-01 → 2017-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥903m2016-01-01 → 2016-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥756m2015-01-01 → 2015-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥814m2014-01-01 → 2014-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥599m2013-01-01 → 2013-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥132m2017-01-01 → 2017-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥257m2016-01-01 → 2016-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥1.8bn2015-01-01 → 2015-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.4bn2014-01-01 → 2014-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥110m2013-01-01 → 2013-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.5bn2017-01-01 → 2017-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥6m2016-01-01 → 2016-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥120m2015-01-01 → 2015-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥233,0002014-01-01 → 2014-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥5.4bn2013-01-01 → 2013-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-106.232017-01-01 → 2017-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-101.182016-01-01 → 2016-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-93.352015-01-01 → 2015-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-80.552014-01-01 → 2014-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-94.332013-01-01 → 2013-12-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥263.54at 2017-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥283.43at 2016-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥381.27at 2015-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥476.03at 2014-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥561.17at 2013-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio82.9%at 2017-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2016-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio87.2%at 2015-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.2%at 2014-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio89.3%at 2013-12-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued11,086,000at 2017-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,234,600at 2016-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,183,800at 2015-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,183,200at 2014-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued9,076,900at 2013-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees29at 2017-12-31StandaloneNumber of employees
Employees30at 2016-12-31StandaloneNumber of employees
Employees29at 2015-12-31dStandaloneNumber of employees
Employees28at 2014-12-31dStandaloneNumber of employees
Employees22at 2013-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2017-01-01 → 2017-12-31¥1m
Reconciling Itemsreconcilingsegment profit2017-01-01 → 2017-12-31−¥537m
Diagnostic Divisionreportable segmentrevenue2017-01-01 → 2017-12-31¥33m
Diagnostic Divisionreportable segmentrevenue external2017-01-01 → 2017-12-31¥33m
Diagnostic Divisionreportable segmentsegment profit2017-01-01 → 2017-12-31−¥104m
Pharmaceutical Divisionreportable segmentrevenue2017-01-01 → 2017-12-31¥197m
Pharmaceutical Divisionreportable segmentrevenue external2017-01-01 → 2017-12-31¥197m
Pharmaceutical Divisionreportable segmentsegment profit2017-01-01 → 2017-12-31−¥438m
Total Of Reportable Segments And Otherssegment totalrevenue2017-01-01 → 2017-12-31¥229m
Total Of Reportable Segments And Otherssegment totalrevenue external2017-01-01 → 2017-12-31¥229m
Total Of Reportable Segments And Otherssegment totalsegment profit2017-01-01 → 2017-12-31−¥542m
Reconciling Itemsreconcilingdepreciation2016-01-01 → 2016-12-31¥4m
Reconciling Itemsreconcilingsegment profit2016-01-01 → 2016-12-31−¥438m
Diagnostic Divisionreportable segmentdepreciation2016-01-01 → 2016-12-31¥11m
Diagnostic Divisionreportable segmentrevenue2016-01-01 → 2016-12-31¥60m
Diagnostic Divisionreportable segmentrevenue external2016-01-01 → 2016-12-31¥60m
Diagnostic Divisionreportable segmentsegment profit2016-01-01 → 2016-12-31−¥105m
Pharmaceutical Divisionreportable segmentrevenue2016-01-01 → 2016-12-31¥119m
Pharmaceutical Divisionreportable segmentrevenue external2016-01-01 → 2016-12-31¥119m
Pharmaceutical Divisionreportable segmentsegment profit2016-01-01 → 2016-12-31−¥318m
Total Of Reportable Segments And Otherssegment totaldepreciation2016-01-01 → 2016-12-31¥11m
Total Of Reportable Segments And Otherssegment totalrevenue2016-01-01 → 2016-12-31¥178m
Total Of Reportable Segments And Otherssegment totalrevenue external2016-01-01 → 2016-12-31¥178m
Total Of Reportable Segments And Otherssegment totalsegment profit2016-01-01 → 2016-12-31−¥423m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 712
ItemContextValueUnit
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Description of rights plan na (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Shareholding by shareholder category (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)アステラス製薬株式会社
Address major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋本町２丁目５-１号
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMemberWONIK CUBE Corp.
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)浦田　泰生
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)松井証券株式会社
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)東京都千代田区麹町１丁目４番地
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)竹林　嘉浩
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)京都府京都市
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)雨堤　正博
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)東京都渋谷区
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)株式会社SBI証券
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)東京都港区六本木１丁目６番１号
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)野村證券株式会社
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋1丁目９－１
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMemberMIZUHO SECURITIES ASIA LIMITED-CLIENT A/C 69250601
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMemberUBS AG SINGAPORE
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMemberAESCHENVORSTADT 1, CH-4002 BASEL, SWITZERLAND
Issued shares voting rights (text)FilingDateInstantText · Plus
Treasury shares etc na (text)FilingDateInstantText · Plus
Details of employee share option program (text)FilingDateInstantText · Plus
Classes of shares etc na (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting na (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting na (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting na (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares na (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Highest and lowest share price of each fiscal year in last five years (text)FilingDateInstantText · Plus
Highest and lowest share price of each month in last six months (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Explanation about corporate governance (text)FilingDateInstantText · Plus
Details of remuneration to independent auditors (text)FilingDateInstantText · Plus
Other material remuneration to independent auditors na (text)FilingDateInstantText · Plus
Details of non audit services rendered by independent auditors na (text)FilingDateInstantText · Plus
Policy on determining audit fee (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYearDurationText · Plus
Note on independent audit financial informationCurrentYearDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYearDurationText · Plus
Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial informationCurrentYearDurationText · Plus
Balance sheet (text)CurrentYearDurationText · Plus
Statement of income (text)CurrentYearDurationText · Plus
Detailed schedule of manufacturing cost (text)CurrentYearDurationText · Plus
Statement of changes in equity (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2016-12-31pass rounding
balance sheet identitynon_consolidated 2017-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2015-12-31pass
statement vs summary · net assetsnon_consolidated 2016-12-31pass
statement vs summary · net assetsnon_consolidated 2017-12-31pass
statement vs summary · operating cash flownon_consolidated 2016-01-01/2016-12-31pass
statement vs summary · operating cash flownon_consolidated 2017-01-01/2017-12-31pass
statement vs summary · revenuenon_consolidated 2016-01-01/2016-12-31pass
statement vs summary · revenuenon_consolidated 2017-01-01/2017-12-31pass
statement vs summary · total assetsnon_consolidated 2016-12-31pass
statement vs summary · total assetsnon_consolidated 2017-12-31pass